Here are five highlights:
1. The two companies partnered in 2012 to co-develop musculoskeletal healthcare diagnostics.
2. Under the initial partnership, Zimmer Biomet marketed the Synovasure Periprosthetic Joint Infection test.
3. CD Diagnostics creates diagnostics assays that help physicians make decisions which optimize patient care.
4. CD Diagnostics’ laboratories have evaluated more than 40,000 samples.
5. The companies did not disclose financial details of the transaction.
“Our acquisition of CD Diagnostics cements our leadership and competitive advantage in musculoskeletal diagnostics, strengthens our Signature Solutions offering and advances our mission to provide comprehensive musculoskeletal healthcare,” said Dan Williamson, group president of joint reconstruction, Zimmer Biomet.
More articles on devices:
Orthopaedic Implant Company launches nail system for femoral midshaft and distal fractures: 5 things to know
Amedica, Mazor Robotics, InVivo Therapeutics & more: 18 key notes
Global medical electronics market to hit $60B by 2023 — 6 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
